Polaris AI Pharma Corp. (KOSDAQ: 041910)

Polaris AI Pharma Statistics

Total Valuation

Polaris AI Pharma has a market cap or net worth of KRW 70.80 billion. The enterprise value is 42.75 billion.

Market Cap	70.80B
Enterprise Value	42.75B

Important Dates

The next estimated earnings date is Friday, March 21, 2025.

Earnings Date	Mar 21, 2025
Ex-Dividend Date	Dec 27, 2024

Share Statistics

Polaris AI Pharma has 13.28 million shares outstanding.

Current Share Class	n/a
Shares Outstanding	13.28M
Shares Change (YoY)	n/a
Shares Change (QoQ)	n/a
Owned by Insiders (%)	n/a
Owned by Institutions (%)	0.32%
Float	9.30M

Valuation Ratios

The trailing PE ratio is 62.92.

PE Ratio	62.92
Forward PE	n/a
PS Ratio	0.97
PB Ratio	0.51
P/TBV Ratio	0.58
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 7.80, with an EV/FCF ratio of -9.11.

EV / Earnings	43.20
EV / Sales	0.67
EV / EBITDA	7.80
EV / EBIT	14.93
EV / FCF	-9.11

Financial Position

The company has a current ratio of 9.62, with a Debt / Equity ratio of 0.01.

Current Ratio	9.62
Quick Ratio	6.48
Debt / Equity	0.01
Debt / EBITDA	0.18
Debt / FCF	-0.22
Interest Coverage	144.64

Financial Efficiency

Return on equity (ROE) is 0.82% and return on invested capital (ROIC) is 1.63%.

Return on Equity (ROE)	0.82%
Return on Assets (ROA)	1.53%
Return on Capital (ROIC)	1.63%
Revenue Per Employee	399.60M
Profits Per Employee	6.18M
Employee Count	160
Asset Turnover	0.50
Inventory Turnover	2.58

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -18.94% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	-18.94%
50-Day Moving Average	5,943.50
200-Day Moving Average	7,707.23
Relative Strength Index (RSI)	42.44
Average Volume (20 Days)	118,697

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Polaris AI Pharma had revenue of KRW 63.94 billion and earned 989.48 million in profits. Earnings per share was 84.72.

Revenue	63.94B
Gross Profit	12.87B
Operating Income	3.16B
Pretax Income	256.35M
Net Income	989.48M
EBITDA	5.78B
EBIT	3.16B
Earnings Per Share (EPS)	84.72

Balance Sheet

The company has 29.07 billion in cash and 1.02 billion in debt, giving a net cash position of 28.05 billion or 2,111.75 per share.

Cash & Cash Equivalents	29.07B
Total Debt	1.02B
Net Cash	28.05B
Net Cash Per Share	2,111.75
Equity (Book Value)	123.22B
Book Value Per Share	10,549.42
Working Capital	60.99B

Cash Flow

In the last 12 months, operating cash flow was -2.87 billion and capital expenditures -1.82 billion, giving a free cash flow of -4.69 billion.

Operating Cash Flow	-2.87B
Capital Expenditures	-1.82B
Free Cash Flow	-4.69B
FCF Per Share	-353.39

Margins

Gross margin is 20.13%, with operating and profit margins of 4.94% and 1.55%.

Gross Margin	20.13%
Operating Margin	4.94%
Pretax Margin	0.40%
Profit Margin	1.55%
EBITDA Margin	9.04%
EBIT Margin	4.94%
FCF Margin	n/a

Dividends & Yields

This stock pays an annual dividend of 100.00, which amounts to a dividend yield of 1.88%.

Dividend Per Share	100.00
Dividend Yield	1.88%
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	118.04%
Buyback Yield	n/a
Shareholder Yield	1.88%
Earnings Yield	1.59%
FCF Yield	-6.63%

Stock Splits

The last stock split was on May 9, 2005. It was a forward split with a ratio of 1.1.

Last Split Date	May 9, 2005
Split Type	Forward
Split Ratio	1.1

Scores

Polaris AI Pharma has an Altman Z-Score of 8.93.

Altman Z-Score	8.93
Piotroski F-Score	n/a